111 related articles for article (PubMed ID: 21360537)
21. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients.
Hirano A; Kamimura M; Ogura K; Kim N; Hattori A; Setoguchi Y; Okubo F; Inoue H; Miyamoto R; Kinoshita J; Fujibayashi M; Shimizu T
Ann Surg Oncol; 2012 Dec; 19(13):4112-6. PubMed ID: 22782671
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye Medical System.
Yamauchi K; Nagafuji H; Nakamura T; Sato T; Kohno N
Ann Surg Oncol; 2011 Jul; 18(7):2042-7. PubMed ID: 21298353
[TBL] [Abstract][Full Text] [Related]
23. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
Simmons RM; Smith SM; Osborne MP
Breast J; 2001; 7(3):181-3. PubMed ID: 11469932
[TBL] [Abstract][Full Text] [Related]
24. Periareolar or Peritumoral Injection of Isosulfan Blue and the Effect on the Number of Sentinel Lymph Nodes Examined.
Weber JJ; Wong JH
Am Surg; 2017 Jan; 83(1):98-102. PubMed ID: 28234133
[TBL] [Abstract][Full Text] [Related]
25. 10 % fluorescein sodium vs 1 % isosulfan blue in breast sentinel lymph node biopsy.
Ren L; Liu Z; Liang M; Wang L; Song X; Wang S
World J Surg Oncol; 2016 Nov; 14(1):280. PubMed ID: 27809854
[TBL] [Abstract][Full Text] [Related]
26. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure.
Woltsche-Kahr I; Komericki P; Kränke B; Brabek E; Horn M; Schuller-Petrovic S; Richtig E; Aberer W
Eur J Surg Oncol; 2000 Apr; 26(3):313-4. PubMed ID: 10753539
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?
Kaviani A; Noveiry BB; Noaparast M
Surgery; 2012 Jul; 152(1):140. PubMed ID: 22386708
[No Abstract] [Full Text] [Related]
28. Subdermal laterocranial mapping of sentinel lymph nodes in breast cancer as an alternative to the peritumoral mapping.
Deliisky T; Ilieva A; Velkova A; Popovska S; Betova T; Baichev G; Daskalova I; Dimitrov D; Nanev V
J BUON; 2008; 13(3):391-3. PubMed ID: 18979555
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.
Shiozawa M; Lefor AT; Hozumi Y; Kurihara K; Sata N; Yasuda Y; Kusakabe M
Breast Cancer; 2013 Jul; 20(3):223-9. PubMed ID: 22240965
[TBL] [Abstract][Full Text] [Related]
30. Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial).
Ahmed M; Anninga B; Goyal S; Young P; Pankhurst QA; Douek M;
Br J Surg; 2015 May; 102(6):646-52. PubMed ID: 25868072
[TBL] [Abstract][Full Text] [Related]
31. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping.
Blessing WD; Stolier AJ; Teng SC; Bolton JS; Fuhrman GM
Am J Surg; 2002 Oct; 184(4):341-5. PubMed ID: 12383897
[TBL] [Abstract][Full Text] [Related]
32. Triple Mapping to Optimize Axillary Management in Breast Cancer Patients After Neoadjuvant Therapy.
Shilad S; Cakmakoglu C; Schwarz G; Valente S; Djohan R; Grobmyer S
Ann Surg Oncol; 2018 Oct; 25(10):3106. PubMed ID: 30006690
[No Abstract] [Full Text] [Related]
33. Blue dye of choice for lymphatic mapping.
Vargas HI
J Clin Oncol; 2005 May; 23(15):3648; author reply 3648-9. PubMed ID: 15908691
[No Abstract] [Full Text] [Related]
34. Anaphylactic shock perioperative to patent blue dye.
Azevedo JP; Alves M; Ribeiro C; Todo Bom A
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29735500
[TBL] [Abstract][Full Text] [Related]
35. Increased post-operative complications with methylene blue versus lymphazurin in sentinel lymph node biopsies for skin cancers.
Neves RI; Reynolds BQ; Hazard SW; Saunders B; Mackay DR
J Surg Oncol; 2011 Apr; 103(5):421-5. PubMed ID: 21400527
[TBL] [Abstract][Full Text] [Related]
36. Tracer agents for the detection of sentinel lymph nodes in breast cancer: current concerns and directions for the future.
Kelley LM; Holmes DR
J Surg Oncol; 2011 Jul; 104(1):91-6. PubMed ID: 21400533
[TBL] [Abstract][Full Text] [Related]
37. Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size.
Viehl CT; Hamel CT; Marti WR; Guller U; Eisner L; Stammberger U; Terracciano L; Spichtin HP; Harder F; Zuber M
World J Surg; 2003 Dec; 27(12):1285-90. PubMed ID: 14595521
[TBL] [Abstract][Full Text] [Related]
38. Real-time near-infrared fluorescence imaging mediated by blue dye in breast cancer patients.
Jiang L; Liu T; Wang X; Li J; Zhao H
J Surg Oncol; 2020 May; 121(6):964-966. PubMed ID: 32103507
[TBL] [Abstract][Full Text] [Related]
39. Upstaging of early colorectal cancers following improved lymph node yield after methylene blue injection.
Jepsen RK; Ingeholm P; Lund EL
Histopathology; 2012 Nov; 61(5):788-94. PubMed ID: 22804356
[TBL] [Abstract][Full Text] [Related]
40. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer.
Cinar H; Koca B; Kesicioglu T; Karabulut K; Karabicak I; Polat C; Tur AH
Breast; 2012 Apr; 21(2):220-2. PubMed ID: 22186354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
